Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October 2024.

To address this, Future Technologies Venture is expanding its engagement model to incorporate private cellular capabilities ...

Researchers have completed the first phase of a collaboration integrating robotic cell processing with automated ...

CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...